Drug industry bets on new blockbusters in 2013

Reuters

Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12 months.

Letter
to the
Editor

Send us a letter

Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

Recommended for You
U.S. Food and Drug Administration (FDA)
Upcoming FDA draft on pulse oximetry's racial bias draws questions
Most Popular
1
Bullets in UnitedHealthcare CEO death inscribed with ‘depose,’ ‘delay’
2
UnitedHealthcare CEO Brian Thompson's killing shocks industry
3
Sutter Health Plus taps ex-Cigna exec as CEO
4
UnitedHealthcare CEO killing puts new focus on exec safety policy
5
Soda Health gets $50M to manage MA supplemental benefits